KIM COOPER: Open Payments
NPI 1750316881 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 8 payments from 4 companies in 2025. Trend: 2023 $35 · 2024 $31 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $94 |
| Novo Nordisk Inc | 1 | $61 |
| ABBVIE INC. | 2 | $49 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: Auvelity, Ozempic, LINZESS, Epclusa.
Industry payments across MS — which companies pay providers there.
